Middle East Office
FDA’s interactions with the Middle East are important because of:
- The sensitivity of products traded with the USA. The increased volume of trade in FDA-regulated products.
- The need to learn more about the regulations of the region to make sure the products destined to US market are safe, effective, wholesome, and secure.
- The increased production of generic drugs in the region.
- The increased number of global drug companies conducting clinical testing in the region.
Slide 2: FY 2010 Goals
Our major objectives for the coming year will be:
- Increase knowledge of counterpart regulatory authorities, USG entities, and international organizations with presence in MENA – continue information collection;
- Continue to triage inquiries from the ME countries;
- Assist in building regulatory and technical capacity at request of counterpart agencies – conduct a food safety workshop in the Middle east; and
- Coordinate and collaborate with USG in-country counterparts with complementary missions and with international organizations with activities in the Middle East.